High Tower Advisors, LLC Amphastar Pharmaceuticals, Inc. Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$44.49 - $62.93 $306,358 - $433,335	6,886 Added 114.98%	12,875 $796,000
Q3 2023 Nov 08, 2023	SELL	$45.51 - $65.0 $270,647 - $386,555	-5,947 Reduced 49.82%	5,989 $275,000
Q2 2023 Aug 14, 2023	SELL	$35.77 - $58.38 $3,791 - $6,188	-106 Reduced 0.88%	11,936 $685,000
Q1 2023 May 11, 2023	BUY	$27.99 - $37.92 $55,504 - $75,195	1,983 Added 19.71%	12,042 $451,000
Q4 2022 Feb 08, 2023	BUY	$27.93 - $31.27 $280,947 - $314,544	10,059 New	10,059 $281,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.